Hepatitis C virus (HCV) is a major cause of chronic liver disease worldwide. In addition to established liver injury, type 2 diabetes mellitus is one of the most important extrahepatic metabolic disorders that are attributed to HCV infection.
Introduction
Hepatitis C virus (HCV) is a major cause of acute and chronic liver disease worldwide. HCV is both hepatotropic and lymphotropic, which replicates in diseased extrahepatic organs and tissues and may trigger latent autoimmunity or induce autoimmune disorders [1] .
In addition to established liver injury, type 2 diabetes mellitus (T2DM) is an important feature of extrahepatic metabolic disorders, which is attributed to HCV infection. This interaction between a common endocrine disorder and an infectious disease is an important issue to elucidate.
Insulin resistance (IR) plays an important role in the development of various complications associated with HCV infection. Recent evidence indicates that HCVassociated IR may result in accelerated hepatic fibrosis, steatosis, hepatocellular carcinoma, and resistance to antiviral treatment [2] .
Thus, HCV-associated IR is a therapeutic target at any stage of HCV infection as there is an inverse correlation between the severity of IR and sustained virologic response in HCV patients [3] .
Strikingly, Arase et al. [4] recently showed that HCV treatment may decrease the annual incidence of diabetes in HCV-infected patients, independent of other predisposing factors.
Aghemo et al. [5] confirmed these results, showing that viral eradication after treatment is also able to reduce the occurrence of IR significantly.
The aim of our study was to investigate the impact of HCV infection on glucose metabolism and to highlight the role of inflammatory cytokines in IR development in HCV infection.
Patients and methods

Patients
Our case-control study included 100 patients with chronic HCV who were recruited from the inpatient ward and outpatient clinic of Internal Medicine at Cairo University Hospitals during the period from June 2013 to March 2014. The patients were divided into three groups. The protocol was approved by the ethical committee of Cairo University and an informed consent was obtained.
(1) Group I, which included 50 chronic HCV patients with T2DM. All groups were carefully matched for age, sex, BMI, negative family history of T2DM, fasting blood glucose, and severity of liver disease, which was assessed according to modified Child-Pugh's classification.
They were subjected to the following.
(1) Full detailed medical history including age, occupation and residence, history of drug intake, any associated disease (e.g. hypertension), and any present complaint. A HOMA score close to 1 indicates normal insulin sensitivity. IR is associated with high HOMA scores.
Results
Age distribution among the studied groups
There was no statistically significant difference in age distribution between the three groups (P=0.648) ( Table 1) .
Sex distribution among the studied groups
There was no statistically significant difference in sex distribution between the three groups (P=0.593) ( Fig. 1 ).
As regards the main laboratory parameters included in our study ( (198.28±30.245) and the highest mean insulin secretion was seen in group II (97.476±25.847).
C-reactive protein level mean and SD and its statistical significance
There was a statistically highly significant difference in CRP level between groups I and II (P<0.001) and between groups I and III (P<0.001), and a statistically significant difference between groups II and III (P<0.05) ( Fig. 2 ).
Interleukin 6 level mean and SD and its statistical significance
There was a statistically highly significant difference in IL-6 level between groups I and II (P<0.001) as well as between groups I and III (P<0.001), whereas there was no statistically significant difference between groups II and III (P=0.649) ( Fig. 3 ).
Tumor necrosis factor α level mean and SD and its statistical significance
There was a significant statistical difference in TNF-α level between groups I and II patients (P<0.05), whereas a highly significant statistical difference between groups I and III (P<0.001) and between groups II and III (P<0.001) ( Fig. 4) .
Fasting blood glucose level mean and SD and its statistical significance
There was a statistically highly significant difference in FBG level between groups I and II (P<0.001), between groups I and III (P<0.001), and between groups II and III (P<0.001) ( Fig. 5 ).
Insulin resistance mean and SD and its statistical significance
There was a statistically highly significant difference in IR between groups I and II (P<0.001) and between groups I and III (P<0.001), and a statistically significant difference was found between groups II and III (P<0.05) ( Fig. 6 ). 
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Insulin secretion mean and SD and its statistical significance
There was a statistically highly significant difference in insulin secretion between groups I and II (P<0.001), between groups I and III (P<0.001), and between groups II and III (P<0.001) ( Fig. 7) .
As inflammatory mediators (CRP, IL-6, and TNF-α) induced by HCV were the main features in IR syndrome, it was important to correlate each of them with IR.
Correlation between C-reactive protein and insulin resistance
A statistically highly significant positive direct correlation between IR and CRP (r=0.592, P<0.001) was documented ( Fig. 8 ).
Correlation between interleukin 6 and insulin resistance
A statistically highly significant positive direct correlation between IR and IL-6 (r=0.581, P<0.001) was documented ( Fig. 9 ).
Correlation between tumor necrosis factor α and insulin resistance
A statistically significant positive direct correlation between IR and TNF-α (r=0.404, P<0.004) was documented ( Fig. 10 ).
Discussion
Our study included 100 patients with chronic HCV divided into two groups according to the presence and absence of diabetes, and 25 diabetic patients of matched age, sex, and disease duration were included as the control group.
In our study, we compared the levels of CRP, TNF-α, and IL-6 in the three studied groups to establish a link between HCV and the occurrence of IR.
In our study, there was a statistically highly significant difference in CRP level among the three groups (P<0.001), with the highest mean level among HCV diabetic patients (group I), indicating that there was ongoing inflammation as confirmed by the elevated levels of CRP.
In our study, we found a statistically highly significant positive correlation between CRP level and IR (r=0.592, P<0.001), which means that CRP level increase among HCV patients share in the development of IR in patients with chronic liver disease. This finding is supported by Yudkin et al. [6] , who demonstrated that, in 107 nondiabetic individuals, CRP levels were related to IR. Concentrations of CRP correlated both with those of IL-6 (P<0.0005) and of TNF-α (P<0.0001). These observations could 
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suggest that the cytokines, arising in part from adipose tissue, might themselves be partly responsible for the metabolic, hemodynamic, and hemostatic abnormalities that cluster with IR.
In our study we observed a statistically significant difference in the level of IL-6 in group I as compared with group II, as well as between groups I and III (P<0.001), whereas there was no statistical significance between level of IL-6 in groups II and III (P=0.649).
These findings are supported by Kasprzak et al. [7] , who demonstrated an augmented expression of all proinflammatory cytokines and of IL-1α and IL-6, particularly in the livers of chronic hepatitis C patients as compared with their expressions in the control group.
In our study, we found a statistically significant positive correlation between IL-6 level and IR (r=0.581, P<0.001). This finding is supported by Fernandez-Real et al. [8] , who detected higher plasma IL-6 concentrations in patients with IR and T2DM. The study concluded that IR was a significant and an independent predictor of peripheral IL-6 levels.
Furthermore, Vozarova et al. [9] also showed a positive correlation between plasma IL-6 concentrations and fasting insulin concentrations, an index of IR.
HCV may induce a Th1 lymphocyte immune-mediated response, which leads to the activation of the TNF-α system and elevation of IL-6 levels. A high TNF-α level was considered to be one of the bases of IR [10] .
In our study, there was a statistically significant difference in the level of TNF-α between groups I and II (P<0.05), between groups I and III (P<0.001), and between groups II and III (P<0.001).
Furthermore, a statistically significant positive correlation was observed between TNF-α and IR (r=0.403, P=0.004).
Our findings are supported by Lecube et al. [10] , who provided the first clinical evidence of elevated levels of TNF-α and IL-6 in nondiabetic HCV-positive patients.
An earlier study of liver biopsy specimens from nondiabetic HCV patients revealed significant impairments in the insulin signaling pathway, which The mean and SD among the three groups showing that it is higher in group II as compared with groups I and III.
are strikingly similar to the known effects of TNF-α and can lead to IR [11] .
A study by Festa et al. [12] showed that chronic subclinical inflammation is a part of the IR syndrome. Moreover, in cross-sectional studies, levels of inflammatory biomarkers such as CRP and the proinflammatory cytokines IL-6 and TNF-α correlated with insulin sensitivity and with features of the IR syndrome [13] .
Our study is one of the few studies that measured serum levels of TNF-α in patients with chronic HCV either diabetic or nondiabetic and confirmed the previous study by denoting the highly significant positive correlation between level of CRP, IL-6, TNF-α, and IR.In our study, the mean level of HOMA-IR was higher in diabetic HCV patients compared with the other groups. This finding was supported by Delgado et al. [14] , who showed that 62% of patients with HCV had IR.
In our current study, nondiabetic patients with HCV (group II) had higher levels of insulin secreted from the β cells of the pancreas compared with other groups. There was a statistically highly significant difference (P<0.001) in insulin secretion between groups I and II, between groups I and III, and between groups II and III.
Although there are a limited number of studies that assess insulin secretion from the β cells of the pancreas, a study by Lecube et al. [10] was able to hypothesize that a deficit in insulin secretion is another potential mechanism involved in diabetes associated with HCV infection. This in part explains why in our study there were lower levels of insulin secretion in HCV diabetic patients compared with the other studied groups.
Conclusion
HCV is a major cause of acute and chronic liver disease worldwide. In addition to established liver injury, T2DM is an important feature of extrahepatic metabolic disorders, which is attributed to HCV infection. High levels of proinflammatory cytokines (e.g. CRP, TNF-α, and IL-6) as markers of the innate immunity have been found in HCV-infected patients and thereby they could be involved in the pathogenesis of IR associated with HCV.
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